糖肾康治疗糖尿病肾病的临床与实验研究(Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang).docVIP
- 3
- 0
- 约8.37千字
- 约 8页
- 2017-09-15 发布于河南
- 举报
糖肾康治疗糖尿病肾病的临床与实验研究(Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang)
糖肾康治疗糖尿病肾病的临床与实验研究(Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang)
Clinical and experimental study on diabetic nephropathy treated with Shen Shen Kang
Update Date: 2009-04-24 click:
Tong Jie Shi Hong Cao Gang
Objective: To evaluate the therapeutic effect of diabetic nephropathy treated by Shen Shen Kang capsule. Methods: 300 patients with diabetic nephropathy were randomly divided into 200 groups, and 100 cases were treated with Kato Pury capsule. Results compared with the control group, the effective rate of the capsule was significantly different (P 0.05). The results of animal experiments showed that Tangshenkang capsule has the hypoglycemic effect on diabetic rabbits; can significantly improve the glucose tolerance in rats; reduce the effect on proteinuria in nephrotic rats; Tangshenkang capsule high dose absorption with no obvious side effect. Conclusion: the Chinese herbal medicine Kang Shen Kang Capsule has a good effect in relieving symptoms, reducing urinary protein and stabilizing blood sugar.
Keywords sugar kidney capsule; diabetic nephropathy; urine protein; blood sugar;
CLC number: R 289.5, document identifier code: A
Article number: 1007-5615 (2000) 03-0005-04
Diabetic nephropathy (DN) is one of the three leading causes of diabetes death. Chinese medicine treatment of this disease reported many, the effective rate is between 60% and 70%. In combination with the clinical practice, the treatment of this disease from the liver, with the principle of soothing the liver and regulating qi and invigorating the kidney and promoting blood circulation, the effective rate of the clinical treatment was 90%, and the pharmacodynamics test was carried out. The result is as follows.
1 clinical observation
1.1 clinical data 300 patients all according to WHO diagnostic criteria [1] diagnosed diabetes, and use Gao Yanbins diabetic nephropathy diagnostic staging criteria [2].
All cases excluded renal insufficiency caused by cardiac in
您可能关注的文档
- 管理40(Manage 40).doc
- 管棒型-表面高低倍要求(Tube rod type - surface high and low requirements).doc
- 简单的自制中药面膜配方(Simple homemade Herbal Mask formula).doc
- 管理人才选拔的三大误区(Three misunderstandings in the selection of managerial personnel).doc
- 管卫东教你如何解除gmat考前心理障碍(Guan Weidong teaches you how to get rid of mental disorders before GMAT exams).doc
- 管理信息系统复习内容总结(Management information system review content summary).doc
- 管理信息系统(management information systems).doc
- 管理会计自考2009年7月试题与答案txt版(Management accounting exam July 2009 examination questions and answers TXT Edition).doc
- 管理学论文--公路企业中的工程物资管理(Management papers -- management of engineering materials in highway enterprises).doc
- 管理学课后题答案(Management answers questions after class).doc
最近下载
- 2025-2030中国氮化铝粉行业市场发展趋势与前景展望战略研究报告.docx
- 混凝土路面砖JC446-2000标准.pdf VIP
- 三相交流系统短路容量计算及编制说明.pdf VIP
- SH_T 3408-2022 石油化工钢制对焊管件技术规范.docx
- JC_T 2453-2018中空玻璃间隔条 第3部分:暖边间隔条.pdf
- 太阳能模拟软件:SAM二次开发_(4).SAM数据输入与管理.docx VIP
- ISO 9001 2026 DIS新版标准核心变化点解读教材.pdf VIP
- 二十届中纪委五次全会知识测试题及答案解析.doc VIP
- 2025年吊带技术规范标准[详].pdf VIP
- 安全生产管理组织机构图.doc VIP
原创力文档

文档评论(0)